Correction: Protein domain-specific genotype-phenotype correlation study of neurofibromatosis type 1. [PDF]
Ou M +7 more
europepmc +1 more source
Quantitative measurement of cutaneous neurofibromas in neurofibromatosis type 1 using a structured-light scanner. [PDF]
Hartung TI +4 more
europepmc +1 more source
Utility of 18F-FDG PET/CT in the Surveillance of Patients With Neurofibromatosis Type 1. [PDF]
Tanase MG +11 more
europepmc +1 more source
Neurofibromatosis type 1: an illustrative case of cutaneous manifestations. [PDF]
Itankar PB, Sawarkar GR.
europepmc +1 more source
MEK inhibitors for neurofibromatosis type 1-associated central and peripheral nervous system tumors. [PDF]
Kotch C +3 more
europepmc +1 more source
Genetic and non-genetic factors influencing phenotypic variability in neurofibromatosis type 1. [PDF]
Clissa PB, Sanabani SS.
europepmc +1 more source
Severe Necrotizing Pneumonia as an Unusual Initial Manifestation of Neurofibromatosis Type 1: A Case Presentation. [PDF]
Anyfanti P +14 more
europepmc +1 more source
Isolated Anterior Mesenteric Neurofibroma: A Rare Manifestation of Neurofibromatosis Type 1. [PDF]
Ouassil S +11 more
europepmc +1 more source
Neurofibromatosis Type 1 with Plexiform Neurofibroma: A Novel Mutation Uncovered. [PDF]
Garg P +4 more
europepmc +1 more source
Neurofibromatosis type 1-plexiform neurofibromas: Integrating treatment across pediatric and adult populations. [PDF]
Armstrong AE +7 more
europepmc +1 more source

